Merck Completes Acquisition of Pandion Therapeutics
Go back to Merck Completes Acquisition of Pandion Therapeutics| Merck & Co. (NYSE: MRK) | Delayed: 120.60 +1.00 (0.84%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $119.60 | 52 Week High | $65.46 | |||
| Open | $120.90 | 52 Week Low | $47.97 | |||
| Day High | $121.81 | P/E | 82.04 | |||
| Day Low | $119.51 | EPS | $1.47 | |||
| Volume | 10,478,095 | |||||
| (NASDAQ: PAND) | Delayed: 60.05 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $60.05 | 52 Week High | $ | |||
| Open | $35.76 | 52 Week Low | $ | |||
| Day High | $60.05 | P/E | N/A | |||
| Day Low | $60.05 | EPS | $ | |||
| Volume | 1,360 | |||||
